State of the science on mild cognitive impairment (MCI)

Nicole D Anderson1

  • 1Departments of Psychology and Psychiatry,University of Toronto,Rotman Research Institute,Baycrest Health Sciences,Toronto,Ontario,Canada.

CNS Spectrums
|January 18, 2019
PubMed

Insights

Mild cognitive impairment (MCI) is a stage between aging and dementia. Research focuses on biomarkers and interventions to delay its progression to Alzheimer's disease (AD).

Area of Science:

  • Neurology
  • Neuroscience
  • Gerontology

Background:

  • Mild cognitive impairment (MCI) affects 10-15% of individuals over 65, representing a critical transitional phase toward dementia.
  • Alzheimer's disease (AD) drug trial failures necessitate a shift towards delaying MCI progression to reduce dementia prevalence and healthcare costs.
  • Current MCI diagnostics increasingly require positive biomarkers for preclinical AD detection, alongside cognitive assessments.

Purpose of the Study:

  • To review the phenomenology, neurobiology, assessment methods, and potential interventions for mild cognitive impairment (MCI).
  • To highlight the need for improved diagnostic tools and strategies to delay the progression of MCI to dementia.
  • To discuss the current understanding and future directions in managing MCI.

Main Methods:

  • Review of current literature on MCI phenomenology, neurobiology, and diagnostic criteria.
  • Analysis of neuroimaging (PET, EEG, MEG) and cerebrospinal fluid (CSF) biomarkers for MCI detection.
  • Evaluation of existing and potential interventions, including pharmacological, lifestyle, and psychoeducational approaches.

Main Results:

  • MCI is characterized by reduced quality-of-life, depression, and social withdrawal.
  • Neurobiological hallmarks include temporoparietal hypoperfusion, medial temporal lobe atrophy, and altered CSF Aβ42 and tau levels.
  • Positron emission tomography (PET) for tau and electroencephalography (EEG)/magnetoencephalography (MEG) signal complexity show promise as biomarkers.

Conclusions:

  • There is an urgent need for standardized cognitive tests and validated biomarkers to accurately assess MCI and detect preclinical AD.
  • While cholinesterase inhibitors are used, lifestyle interventions (exercise, diet) and psychoeducational programs show promise in enhancing cognitive reserve.
  • Further research is essential to fully elucidate MCI's phenomenology and neurobiology for effective dementia prevention strategies.

Related Concept Videos

Cognitive Dissonance01:38

Cognitive Dissonance

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.5K
Psychology as a Science01:13

Psychology as a Science

Psychology, as a scientific discipline, aims to understand the mind and behavior through rigorous and systematic methods. The foundation of psychological research is evidence-based, relying heavily on the scientific method to derive and validate knowledge. This structured approach ensures that findings are reliable, valid, and applicable to broader contexts.
The scientific method in psychology involves six critical steps: making observations, formulating hypotheses, conducting tests, analyzing...
3.9K
Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
5.2K
Statistical Package for the Social Sciences (SPSS)01:22

Statistical Package for the Social Sciences (SPSS)

The Statistical Package for the Social Sciences, or SPSS, is a data management and analysis software suite. Developed by SPSS Inc. in 1968 and acquired by IBM in 2009, this tool was initially designed for social science data analysis, evolving to serve a wider range of disciplines. It was later renamed to Statistical Product and Service Solutions.
SPSS streamlines the process from data preparation to analysis and reporting. It is characterized by its user-friendly interface, which conceals...
1.2K